- 4
- 0
- 约1.34千字
- 约 40页
- 2021-09-17 发布于广东
- 举报
生物技术药物药代动力学特点与检测工作;生物技术药物的药代动力学特点及检测;Cumulative Revenues of Selected Biotechnology Companies (Amgen, Genentech, Chiron, Genzyme and Biogen);Selected Blockbuster Protein Pharmaceuticals;生物技术药物;蛋白肽类药物药代动力学;蛋白肽类药物吸收;Correlation between MW and the cumulative recovery of sc rINF alpha-2a, cytochrome c, inulin and 5-fluoro-2 -deoxyuridine (FUDR) in the efferent lymph in sheep;蛋白肽类药物吸收;IM 和SC给药生物利用度;Pharmacokinetics of IM ADI-SS PEG 20,000 mw in humans with hepatocellular carcinoma;Intranasal administration;Inhalation administration;Plasma bioavailability of therapeutic peptides versus MW after pulmo
原创力文档

文档评论(0)